98 hasil
Menampilkan 1–20 · 0,11 detik · RSS
Lymphatics
Scopus
ISSN 2813-3307 · MDPI AG · 98 artikel di indeks
-
Artikel Jurnal Teks lengkap
Factors Associated with Palliative-Intent Treatment Receipt in Cutaneous T-Cell Lymphoma
Cutaneous T-cell lymphoma (CTCL) is a chronic, generally incurable group of non-Hodgkin lymphomas associated with substantial symptom burden, yet receipt of palliative-intent treatment in this population remains uncharacterized. We conducted a cross-sectional retrospective study of 13,215 patients…
-
Artikel Jurnal Teks lengkap
Cholesterol in Lymphoma and Hematolymphoid Malignancies: Biological Mechanisms, Clinical Associations, and Therapeutic Implications
Cholesterol is increasingly recognized as a regulator of hematolymphoid malignancy biology, by influencing tumor proliferation, immune function, and therapeutic response. This review summarizes current evidence regarding the relationship between cholesterol metabolism and hematologic malignancies…
-
Artikel Jurnal Teks lengkap
The Immunologically Cold Prostate Cancer Microenvironment: How Lymphatic Dysfunction Sustains Immune Evasion
Prostate cancer is the prototypical immunologically cold solid tumor, with objective response rates of only 3–5% to immune checkpoint inhibitors in unselected metastatic castration-resistant disease and an estimated 89.8% of tumors classified as immunologically ignorant. Three convergent features…
-
Artikel Jurnal Teks lengkap
Should the Lymphatic System Be Treated as an Organ at Risk? Reframing Lymphedema as a Preventable Radiotherapy-Planning Toxicity
Lymphedema is usually approached as a survivorship complication; yet, many of the injuries that produce lymphatic failure begin during cancer treatment planning. Regional nodal irradiation, chemoradiation, lymph-node surgery, systemic therapy, obesity, infection history, and baseline lymphatic…
-
Artikel Jurnal Teks lengkap
Hodgkin Lymphoma in a Patient with Down Syndrome: Case Report and Review of the Literature
The association between Down syndrome (DS) and Hodgkin lymphoma (HL) is rare, with only a few cases reported in the literature. Here, we report the case of a pediatric patient with DS diagnosed with HL. In addition, a literature review was conducted, identifying only seven pediatric cases. We…
-
Artikel Jurnal Teks lengkap
The Diagnosis, Imaging and Management of Lymphedema
Lymphedema is a chronic, progressive disorder caused by impaired lymphatic drainage. It leads to swelling, inflammation, fibrosis, increased infection risk, and reduced quality of life. Diagnosis is primarily clinical and is supported by limb measurements, functional assessment, and imaging…
-
Artikel Jurnal Teks lengkap
Inflammatory Breast Cancer-Related Lymphedema
Background: Breast cancer-related lymphedema (BCRL) is a potentially debilitating outcome following breast cancer treatment. Much attention has been given to preventive and curative strategies for BCRL. Patients with inflammatory breast cancer (IBC) are at particularly increased risk, with…
-
Artikel Jurnal Teks lengkap
Draining the Brain: A Novel Noninvasive Lymphatic Therapy for Parkinson’s Disease
The discovery of the glymphatic system and meningeal lymphatic vessels established that the brain possesses an organized lymphatic clearance network that drains to the deep cervical lymphatics. Disruption of this system has been suggested to contribute to the accumulation of pathogenic proteins…
-
Artikel Jurnal Teks lengkap
Protein Homeostasis Networks in Lymphoid Malignancies: Mechanisms of Proteostasis Addiction and Therapeutic Vulnerabilities
Lymphoid malignancies comprise a diverse group of hematologic cancers characterized by extensive genetic, epigenetic, and microenvironmental heterogeneity. Despite substantial advances in targeted therapies and immunotherapeutic approaches, disease relapse and therapeutic resistance remain major…
-
Artikel Jurnal Teks lengkap
CD5 Expression by Innate Lymphoid Cells Type 2 in Multiple Myeloma Before and After Hematopoietic Stem Cell Transplantation
Multiple myeloma (MM) is a malignant plasma cell disorder and one of the most common tumors of lymphoid origin. In the process of oncogenesis, there is a significant change in the immune balance in the body, which leads to the suppression of the immune response to the tumor. This immune suppression…
-
Artikel Jurnal Teks lengkap
Cytoreduction-Adapted Outpatient Venetoclax Ramp-Up in CLL/SLL: A Real-World Pilot Study
Venetoclax-based therapy is effective in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), but tumor lysis syndrome (TLS) risk necessitates a resource-intensive five-week dose ramp-up with intravenous hydration, frequent laboratory monitoring, and clinic-based observation, creating…
-
Artikel Jurnal Teks lengkap
Accessible Indirect Lymphography with Iohexol for Sentinel Lymph Node Mapping in a Dog with Auricular Melanoma: A Brief Report
Sentinel lymph node (SLN) mapping plays a pivotal role in oncological staging in veterinary medicine. However, conventional techniques often depend on radioactive tracers or specialized imaging equipment that is unavailable in many clinical settings. This brief report describes the use of indirect…
-
Artikel Jurnal Teks lengkap
Mobility Matters—Rethinking Compression Therapy in Lymphedema and Phlebolymphedema
Lymphedema and phlebolymphedema are increasingly recognized as prevalent chronic conditions that extend beyond traditional cancer-related populations. Although Complete Decongestive Therapy remains the foundation of management, real-world treatment success is often limited by challenges with…
-
Artikel Jurnal Teks lengkap
Clinical Experience with Venetoclax and Its Safety in Patients with Chronic Lymphocytic Leukemia in Later Lines of Treatment: A Multicenter Analysis from Slovakia
The treatment of chronic lymphocytic leukemia (CLL) has shifted from chemoimmunotherapy to targeted therapy, resulting in improved outcomes and patient survival. The aim of this study was to evaluate the efficacy and safety of venetoclax-based regimens in patients with relapsed/refractory CLL, as…
-
Artikel Jurnal Teks lengkap
Adverse Events of CD19- and BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy: An Analysis of the FDA Adverse Events Database
Background: Chimeric antigen receptor T-cell (CAR-T) therapies have transformed the treatment of haematologic malignancies, yet their adverse event (AE) profiles across all approved agents have not been consolidated using a pharmacovigilance methodology in a single comparative analysis. Methods…
-
Artikel Jurnal Teks lengkap
Nodal Staging and Response Assessment in Locally Advanced Mismatch Repair–Deficient Colon and Rectal Cancer in the Era of Neoadjuvant Immune Checkpoint Inhibitors
Mismatch repair–deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancers exhibit high mutational burden and abundant neoantigen formation, generating a highly immunogenic tumour microenvironment characterised by dense lymphocytic infiltration and strong sensitivity to immune…
-
Artikel Jurnal Teks lengkap
Peripheral T-Cell Lymphoma NOS: Current Management and Emerging Therapeutic Strategies
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T-cells and account for approximately 10% of all non-Hodgkin lymphomas. PTCL not otherwise specified (PTCL-NOS) is the most common subtype and is considered a diagnosis of exclusion…
-
Artikel Jurnal Teks lengkap
Logic-Gated CAR T Cells Effective Against Acute Myeloid Leukemia—Current Status and Future Prospects
Acute myeloid leukemia (AML) presents significant challenges for CAR T-cell therapy due to its pronounced heterogeneity and the lack of leukemia-specific surface antigens. Frequently targeted antigens, such as CD33, CD123, and CLL-1, are also present on normal hematopoietic progenitors, resulting…
-
Artikel Jurnal Teks lengkap
The LUMINA Framework: Development of a Theory-Informed Conceptual Model for Chronic Uncertainty and Treatment Burden in Lymphoid Neoplasms
Lymphoid neoplasms such as multiple myeloma (MM), indolent non-Hodgkin lymphoma, and chronic lymphocytic leukemia are increasingly managed as chronic, relapsing conditions characterized by prolonged surveillance, repeated treatment transitions, and cumulative self-management demands. These…
-
Artikel Jurnal Teks lengkap
A Narrative Review of Lymphedema Following Head and Neck Cancer Treatment
Head and neck lymphedema (HNL) is a common complication of head and neck cancer (HNC) treatment. Surgery and radiation, the backbones of HNC treatment, disrupt lymphatic networks through direct injury and fibrosis, leading to accumulation of lymphatic fluid in interstitial spaces. This causes…